Device Trial Radar · NCT05872035
Smartphone Enabled Hearing Study
Last checked: Nov 19, 2026Latest source record: Oct 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
118
Actual
Start
Apr 20, 2023
Primary completion
Aug 17, 2023
Study completion Aug 17, 2023
Sponsor
- Lead sponsor
- Apple Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- IQVIA Pty Ltd
- First posted
- May 24, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Validation of non-inferiority between headphone amplification settings determined by a participant and settings established by audiologist best practices in individuals 18 years or older.
Conditions
- Hearing
Interventions
Apple SoftwareDevice
Amplification settings established by algorithm and further adjusted by participants per their preference
by AudiologistDevice
Amplification settings established by clinical reference and further adjusted by an audiologist per current best practice
Primary outcomes
What the sponsor says the trial is designed to measure.
- International Outcome Inventory for Hearing Aids (IOI-HA) Survey ResultsTime frame: Approximately 18-31 days upon enrollment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
IQVIA
Overland Park, Kansas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.